We are proud to introduce the AttractAdria consortium partner: Jadran – Galenski Laboratorij (JGL), from Rijeka, Croatia.
About JGL
JGL is a pharmaceutical company in which creativity and passion, openness to challenges and belief in the future are the main drivers of development. JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it is an international pharmaceutical company ( a total of 50 markets worldwide) aimed at developing and manufacturing drugs in target therapeutic areas, with a focus on the senses.
Since the beginning of 2021, JGL has significantly increased focus and investments in internal R&D projects and own intellectual property. Their scientific operations are organised around three important pillars: research and development, process development and global regulatory affairs.
Areas of expertise:
- Sterile solutions based on SW, MD category,
- Sterile solutions of ophthalmic drugs with preservative,
- Sterile nasal solutions, PF-RX,
- Sterile ophthalmic solutions, OF-MD.
The vision that inspires and guides JGL is described in the statement: JGL wants to become a global pharmaceutical company specialized in development and production of value-added sterile products in the segment of ophthalmology and ENT, and leader in the use of sea water for health purposes.